Central corneal thickness in the European Glaucoma Prevention Study
The European Glaucoma Prevention Study Group (EGPS)
Ophthalmology, 2006, (Epub Nov 22).
2006
Central corneal thickness in the European Glaucoma Prevention Study
Central corneal thickness in the European Glaucoma Prevention Study
The European Glaucoma Prevention Study Group (EGPS)
Ophthalmology, 2006, (Epub Nov 22).
2006
Fluorometria, Electrofisiologia, Mapa Macular Digital e Psicofísica.
Fluorometria, Electrofisiologia, Mapa Macular Digital e Psicofísica.
Cunha-Vaz J., Bernardes R., Castelo-Branco M.
In Retinopatia Diabética. Tratado Médico Quirurgico, Ed. Villalba, Figueiroa, M.s., Alfaro, D.V., Gonzalez-Vivas, R., Gomez-Ulla, F., Quiroz-Mercado, H.; 2006; pp. 89-104.
2006
Retinal Leakage Analysis.
Retinal Leakage Analysis.
Bernardes R.
European Vitreoretinal Update 2006. 6TH EURETINA Congress, Lisbon, Portugal, May 18-21, 2006, 5:14-5:15.
2006
Comparison of retinal thickness measurements obtained by Retinal Thickness Analyzer (RTA II) and Optical Coherence Tomography (Stratus OCT) in healthy subjects.
Comparison of retinal thickness measurements obtained by Retinal Thickness Analyzer (RTA II) and Optical Coherence Tomography (Stratus OCT) in healthy subjects.
Nunes S., Baptista P., Bernardes R., Cunha-Vaz J.
In order to compare retinal thickness using the Retinal Thickness Analyzer (RTA II) and the Optical Coherence Tomography (Stratus OCT), 34 eyes from 20 volunteers, aged from 40 to 60 years, were examined in the same session. To allow for a
direct comparison, a new retinal thickness map based on the RTA raw data was developed to produce OCT-like maps. For each area of both maps, the mean, SD and 95% CI of the mean retinal thickness were computed. Statistical significant differences, in the mean retinal thickness obtained by both techniques, were found with the Stratus OCT presenting higher retinal thickness values in all areas. The reliability of the two techniques, assed by the Intra-Class Correlation coefficient (to assess for consistency in retinal thickness measurements) and by the Cohen’s Kappa statistics (to asses for agreement between techniques), is moderate to good. For the agreement analysis we considered absolute agreement when both techniques showed the same behavior (increase or decrease over the 95% CI of the mean retinal thickness or both on the normal range), absolute disagreement when both techniques showed opposite behavior (increase/decrease or decrease/increase over the 95% CI of the mean retinal thickness), and disagreement otherwise. Best ICC consistency of data and agreement between techniques were found on the central 1 mm disc area (ICC = 0.734 and k = 0.686), where the Stratus OCT has higher density of retinal thickness measurements.
Exp. Ophthalmol. 2006, 32 (1): 13-19.
2006
Increased Resolution Macular Thickness Mapping by OCT.
Increased Resolution Macular Thickness Mapping by OCT.
Bernardes R., Santos T., Cunha-Vaz J.
Optical coherence tomography (OCT) poor mapping resolution has been pointed out as the biggest disadvantage of this technique when compared to others, e.g., retinal thickness analyzer. In this work we were able to solve this problem by developing an atlas of macular thickness of the human retina into which OCT scans were thereafter registered. This atlas is used to allow registering OCT scans from the Fast Macular Protocol, thus bringing OCT scans into the atlas coordinates, therefore correcting for misfixations, while simultaneously allowing to perform OCT inter-scan registration. From this initial registration, we were able to compute a thickness map into which Fast RNFL Protocol scans were merged, thus allowing for increased OCT mapping resolution.
Proceedings of the 28th IEEE EMBS Annual International Conference, New York City, USA, Aug 30 Sept 3, 2006, 4710-4713, ISBN 14244-0033-3.
2006
Diabetic Retinopathy. What the primary physician should know.
Diabetic Retinopathy. What the primary physician should know.
Cunha-Vaz, J.G.
Int. Diabetes Monitor. 2005, 17(2):6-9.
2005
Authors Reply to: Progression of retinopathy in type 2 diabetes by Eva Kohner.
Authors Reply to: Progression of retinopathy in type 2 diabetes by Eva Kohner.
Cunha-Vaz, J.G
Int. Diabetes Monitor. 2005, 17(2):16-18.
2005
Results of the European Glaucoma Prevention Study.
Results of the European Glaucoma Prevention Study.
The European Glaucoma Prevention Study Group (EGPS)
Ophthalmology. Ophthalmology 2005; 112:366-375.
2005
A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti-Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema.
A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti-Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema.
The Macugen Diabetic Retinopathy Study Group
Ophthalmology 2005, 112:1747-57.
2005
Visual Acuity Testing. A review.
Visual Acuity Testing. A review.
Duarte, L.
Exp. Ophthalmol. 31/1, 2005, 21-28.
2005